Recall
FDAHealthNovember 13, 2025

Lupin Pharmaceuticals Inc. — Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples,

⚠️ Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

Is this relevant to me?

Geography
FL, MA, MI, OH
Source agency
FDA
Category
Health
Published
November 13, 2025

FL, MA, MI & OH

What's affected?

Product
Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01
UPC
0370748274019
Lot code
WB00006

Additional details

Lot #: WB00006, Exp 12/31/2026

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 32736 vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.